Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methl-11C]WAY-100635, in monkey and human plasma by HPLC: Comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET
- 1 July 1996
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 23 (5) , 627-634
- https://doi.org/10.1016/0969-8051(96)00061-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- First delineation of 5-HT1A receptors in human brain with PET and [11C]WAY-100635European Journal of Pharmacology, 1995
- A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635European Journal of Pharmacology, 1995
- Characterisation of the Binding of [3H]WAY‐100635, a Novel 5‐Hydroxytryptamine1A Receptor Antagonist, to Rat BrainJournal of Neurochemistry, 1995
- [11C]WAY 100635: A radioligand for imaging 5-HT1A receptors with positron emission tomographyLife Sciences, 1994
- Evaluation of [O-methyl-3H]WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brainEuropean Journal of Pharmacology, 1994
- Selective in vivo labelling of brain 5-HT1A receptors by [3H]WAY 100635 in the mouseEuropean Journal of Pharmacology, 1994
- Metabolism of the PET ligand [11C]SCH 23390. Identification of two radiolabelled metabolites with HPLCHuman Psychopharmacology: Clinical and Experimental, 1994
- Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain — a combined in situ hybridisation/in vitro receptor autoradiographic studyBrain Research, 1991
- [3H]5-Methyl-urapidil labels 5-HT1A receptors and α1-adrenoceptors in the rat CNS. In vitro binding and autoradiographic studiesEuropean Journal of Pharmacology, 1991